Incidence of Cushing’s syndrome and Cushing’s disease in commercially-insured patients <65 years old in the United States Michael S. BroderMaureen P. NearyWilliam H. Ludlam OriginalPaper 07 May 2014 Pages: 283 - 289
Octreotide LAR treatment of acromegaly in “real life”: long-term outcome at a tertiary care center Ana Laura Espinosa-de-los-MonterosBaldomero GonzalezMoises Mercado OriginalPaper 30 April 2014 Pages: 290 - 296
Effects of low dose versus high dose human growth hormone on body composition and lipids in adults with GH deficiency: a meta-analysis of placebo-controlled randomized trials Connie B. NewmanJohn D. CarmichaelDavid L. Kleinberg Original Paper 09 May 2014 Pages: 297 - 305
KISS1 receptor is preferentially expressed in clinically non-functioning pituitary tumors Marianna YaronUlrich RennerYona Greenman OriginalPaper 10 May 2014 Pages: 306 - 311
Insulin resistance, metabolic syndrome and chronic low grade inflammation in Sheehan’s syndrome on standard replacement therapy: a case control study Manzoor Ahmad BhatBashir Ahmad LawayIdrees Mubarik OriginalPaper 31 May 2014 Pages: 312 - 318
Importance of cannulated prolactin test in the definition of hyperprolactinaemia M. B. WhyteS. PramodhS. J. B. Aylwin OriginalPaper 31 May 2014 Pages: 319 - 325
Stereotactic radiosurgery for acromegaly: outcomes by adenoma subtype Cheng-Chia LeeMary Lee VanceJason Sheehan OriginalPaper 13 June 2014 Pages: 326 - 334
Low expression of secreted frizzled-related protein 4 in aggressive pituitary adenoma Youtu WuJiwei BaiYazhuo Zhang OriginalPaper 11 June 2014 Pages: 335 - 342
The prevalence and associated factors of colorectal neoplasms in acromegaly: a single center based study Masaaki YamamotoHidenori FukuokaYutaka Takahashi OriginalPaper 20 June 2014 Pages: 343 - 351
Bilateral cerebral infarction in the setting of pituitary apoplexy: a case presentation and literature review Christopher BanerjeeBrian SnellingRicardo J. Komotar OriginalPaper 26 June 2014 Pages: 352 - 358
Up-to 5-year efficacy of pasireotide in a patient with Cushing’s disease and pre-existing diabetes: literature review and clinical practice considerations Laura TrementinoMarina CardinalettiGiorgio Arnaldi OriginalPaper 21 June 2014 Pages: 359 - 365
Persistent self-consciousness about facial appearance, measured with the Derriford appearance scale 59, in patients after long-term biochemical remission of acromegaly S. H. P. P. RoerinkM. A. E. M. WagenmakersR. T. Netea-Maier OriginalPaper 26 June 2014 Pages: 366 - 375
Gamma knife radiosurgery for Cushing’s disease and Nelson’s syndrome Josef MarekJana JežkováLadislav Pecen OriginalPaper 10 July 2014 Pages: 376 - 384
Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study Michael SheppardMarcello D. BronsteinAnnamaria Colao OriginalPaper Open access 08 August 2014 Pages: 385 - 394
Erratum to: Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study Michael SheppardMarcello D. BronsteinAnnamaria Colao Erratum 08 January 2015 Pages: 395 - 396
Extracapsular en bloc resection in pituitary adenoma surgery Eui Hyun KimCheol Ryong KuSun Ho Kim OriginalPaper 27 July 2014 Pages: 397 - 404
Giant prolactinomas: clinical manifestations and outcomes of 16 Arab cases Mussa H. AlmalkiBadurudeen BuharyNaji Aljohani OriginalPaper 26 July 2014 Pages: 405 - 409
Evaluation of survivin splice variants in pituitary tumors Joanna Waligórska-StachuraMirosław AndrusiewiczMarek Ruchała OriginalPaper Open access 09 August 2014 Pages: 410 - 416
Update on prognostic factors in acromegaly: Is a risk score possible? E. Fernandez-RodriguezF. F. CasanuevaI. Bernabeu ReviewPaper 25 May 2014 Pages: 431 - 440